Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence D True

Showing results (111-120 of 204) with videos related to

Pageof 21
Sort By:
JBMR Plus|September 3, 2024
Sclerotic prostate cancer bone metastasis: woven bone lesions with a twistFelipe Eltit, Qiong Wang, Naomi Jung, et al.
The Prostate|January 22, 2013
Characterization of osteoblastic and osteolytic proteins in prostate cancer bone metastasesSandy R Larson, Xiaotun Zhang, Ruth Dumpit, et al.
Oncotarget|October 21, 2016
Mismatch repair deficiency may be common in ductal adenocarcinoma of the prostateMichael T Schweizer, Heather H Cheng, Maria S Tretiakova, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 15, 2026
Detection of prostate cancer in 3D pathology datasets via generative immunolabelingRobert B Serafin, Jennifer Salguero Lopez, Suet Chow, et al.
The Journal of Pathology|February 20, 2013
Tumour cell survival mechanisms in lethal metastatic prostate cancer differ between bone and soft tissue metastasesCanan Akfirat, Xiaotun Zhang, Aviva Ventura, et al.
Nature Communications|March 4, 2021
Inter- and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profilingLauren Brady, Michelle Kriner, Ilsa Coleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
WDR19 expression is increased in prostate cancer compared with normal cells, but low-intensity expression in cancers is associated with shorter time to biochemical failures and local recurrenceBiaoyang Lin, Angelita G Utleg, Karsten Gravdal, et al.
Nature Communications|July 10, 2021
Multiplexed functional genomic analysis of 5' untranslated region mutations across the spectrum of prostate cancerYiting Lim, Sonali Arora, Samantha L Schuster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Guidelines for the development and incorporation of biomarker studies in early clinical trials of novel agentsJanet E Dancey, Kevin K Dobbin, Susan Groshen, et al.
Cell Reports|July 29, 2023
Multi-level functional genomics reveals molecular and cellular oncogenicity of patient-based 3' untranslated region mutationsSamantha L Schuster, Sonali Arora, Cynthia L Wladyka, et al.
Pageof 21

Showing results (111-120 of 204) with videos related to

Sort By:
Pageof 21
JBMR Plus|September 3, 2024
Sclerotic prostate cancer bone metastasis: woven bone lesions with a twistFelipe Eltit, Qiong Wang, Naomi Jung, et al.
The Prostate|January 22, 2013
Characterization of osteoblastic and osteolytic proteins in prostate cancer bone metastasesSandy R Larson, Xiaotun Zhang, Ruth Dumpit, et al.
Oncotarget|October 21, 2016
Mismatch repair deficiency may be common in ductal adenocarcinoma of the prostateMichael T Schweizer, Heather H Cheng, Maria S Tretiakova, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 15, 2026
Detection of prostate cancer in 3D pathology datasets via generative immunolabelingRobert B Serafin, Jennifer Salguero Lopez, Suet Chow, et al.
The Journal of Pathology|February 20, 2013
Tumour cell survival mechanisms in lethal metastatic prostate cancer differ between bone and soft tissue metastasesCanan Akfirat, Xiaotun Zhang, Aviva Ventura, et al.
Nature Communications|March 4, 2021
Inter- and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profilingLauren Brady, Michelle Kriner, Ilsa Coleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
WDR19 expression is increased in prostate cancer compared with normal cells, but low-intensity expression in cancers is associated with shorter time to biochemical failures and local recurrenceBiaoyang Lin, Angelita G Utleg, Karsten Gravdal, et al.
Nature Communications|July 10, 2021
Multiplexed functional genomic analysis of 5' untranslated region mutations across the spectrum of prostate cancerYiting Lim, Sonali Arora, Samantha L Schuster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Guidelines for the development and incorporation of biomarker studies in early clinical trials of novel agentsJanet E Dancey, Kevin K Dobbin, Susan Groshen, et al.
Cell Reports|July 29, 2023
Multi-level functional genomics reveals molecular and cellular oncogenicity of patient-based 3' untranslated region mutationsSamantha L Schuster, Sonali Arora, Cynthia L Wladyka, et al.
Pageof 21